Oral regimen ‘delays onset of MS’
Oral regimen ‘delays onset of MS’
For the first time, an oral therapy has been proven to reduce the risk of developing clinically definite multiple sclerosis in patients with a clinically isolated syndrome. In a phase III trial published in the journal Lancet Neurology, Miller et al clarified the role of teriflunomide (Aubagio) in the treatment of early episodes of demyelinating symptoms suggestive of MS...... Read More - http://www.ms-uk.org/aubagio
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 817 Views
-
Last post by NHE
-
- 0 Replies
- 2281 Views
-
Last post by frodo
-
- 0 Replies
- 1098 Views
-
Last post by NHE
-
- 0 Replies
- 1352 Views
-
Last post by frodo
-
- 1 Replies
- 1050 Views
-
Last post by jimmylegs
-
- 0 Replies
- 1575 Views
-
Last post by NHE
-
- 0 Replies
- 2075 Views
-
Last post by vesta
-
- 1 Replies
- 1136 Views
-
Last post by Petr75